Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes. Part II. - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Journal of Enzyme Inhibition and Medicinal Chemistry Année : 2011

Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes. Part II.

Résumé

Cell cycle progression is dependent on the intracellular iron level and chelators can lead to iron depletion and decrease cell proliferation. This antiproliferative effect can be inhibited by exogenous iron. In this work, we present the synthesis of some new synthetic calix[4]arene podands bearing diamino-tetraesters, diamino-tetraalcohols, diamino-tetraacid and tetraaryloxypentoxy groups at the lower rim, designed as potential iron chelators. We report their effect on cell proliferation, in comparison with the new oral chelator ICL670A (4-[3,5-bis-(2-hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid). The antiproliferative effect of these new compounds was studied in the human hepatocarcinoma HepaRG cell cultures using cell nuclei counting after staining with the DNA intercalating fluorescence dye, Hoechst 33342. Their cytotoxicity was evaluated by the extracellular LDH activity. Preliminary results indicated that their antiproliferative effect was mainly due to their cytotoxicity. The efficiency of these compounds, being comparable to that of ICL670, was independent of iron depletion. This effect remains to be further explored. Moreover, it also shows that the new substituted calix[4]arenes could open the way to valuable new approaches for medicinal chemistry scaffolding.
Fichier non déposé

Dates et versions

hal-00742228 , version 1 (16-10-2012)

Identifiants

Citer

Laurent Latxague, François Gaboriau, Olivier Chassande, Jean-Michel Leger, Viviane Pires, et al.. Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes. Part II.. Journal of Enzyme Inhibition and Medicinal Chemistry, 2011, 26 (2), pp.204-15. ⟨10.3109/14756366.2010.489898⟩. ⟨hal-00742228⟩
123 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More